Seeking Alpha
12 Nov 2025, 02:31 UTC · 44w ago
Esperion Therapeutics, Inc. (ESPR) Discusses Breaking the Statin Intolerance Barrier and Closing the Care Gap in Cardiovascular Health Transcript
Verdict
Headline takes no side. We score ESPR +0.30 — moderately bullish.
- Expected · ESPR
+0.30moderately bullish
−1 bearish0bullish +1More positive than 56% of ticker scores this week





